SEC Info - Alder Biopharmaceuticals Inc - ‘DRS’ from 2/7/14

SEC Info℠

Home

Help

Please Sign In

Alder Biopharmaceuticals Inc – ‘DRS’ from 2/7/14

On: Friday, 2/7/14, at 8:56pm ET · As of: 2/10/14 · Private-to-Public: Filing `¶` – Release Delayed to: 3/19/14 · Accession #: 950123-14-1346 · File #: 377-00475

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/10/14  Alder Biopharmaceuticals Inc      DRS¶        3/19/14   20:5.5M                                   Donnelley … Solutions/FA

Delayed-Release Draft Registration Statement by an Emerging Growth Company or a Foreign Private Issuer — Form DRS
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DRS         Draft Registration Statement by an Emerging Growth  HTML   1.54M 
                Company or a Foreign Private Issuer                              
 2: EX-3        Articles of Incorporation/Organization or By-Laws   HTML     70K 
 3: EX-3        Articles of Incorporation/Organization or By-Laws   HTML     71K 
 4: EX-4        Instrument Defining the Rights of Security Holders  HTML    148K 
 5: EX-10       Material Contract                                   HTML     75K 
 6: EX-10       Material Contract                                   HTML     60K 
 7: EX-10       Material Contract                                   HTML     53K 
 8: EX-10       Material Contract                                   HTML    216K 
 9: EX-10       Material Contract                                   HTML     41K 
10: EX-10       Material Contract                                   HTML     65K 
11: EX-10       Material Contract                                   HTML     80K 
12: EX-10       Material Contract                                   HTML     25K 
13: EX-10       Material Contract                                   HTML     17K 
14: EX-10       Material Contract                                   HTML     25K 
15: EX-10       Material Contract                                   HTML     17K 
16: EX-10       Material Contract                                   HTML     25K 
17: EX-10       Material Contract                                   HTML     17K 
18: EX-10       Material Contract                                   HTML     25K 
19: EX-10       Material Contract                                   HTML     17K 
20: EX-21       Subsidiaries                                        HTML      8K

Filing Submission 0000950123-14-001346 – SGML Text

Original SGML Text submitted by:	Donnelley Financial Solutions/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 5.4M ↑Top ↓Bottom

<SUBMISSION>
<SECARCHIVE-DATETIME>		20190504-013337	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20140319-061659	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20140207-205618	 ⇐ Filing accepted by SEC (ET)
<PRIVATE-TO-PUBLIC>		20140319-061614	 ⇐ Metadata from SEC Info (ET)
<ACCESSION-NUMBER>		0000950123-14-001346
<TYPE>				DRS
<PUBLIC-DOCUMENT-COUNT>		39
<FILING-DATE>			20140210
<PUBLIC-REL-DATE>		20140319	 ⇐ Filing release delayed
<DATE-OF-FILING-DATE-CHANGE>	20140312

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		ALDER BIOPHARMACEUTICALS INC
<CIK>				0001423824
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			000000000
<STATE-OF-INCORPORATION>	DE
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			DRS
<ACT>				33
<FILE-NUMBER>			377-00475
<FILM-NUMBER>			14585970
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			11804 NORTH CREEK PARKWAY SOUTH
<CITY>				BOTHELL
<STATE>				WA
<ZIP>				98011
<PHONE>				425-205-2900
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			11804 NORTH CREEK PARKWAY SOUTH
<CITY>				BOTHELL
<STATE>				WA
<ZIP>				98011
</MAIL-ADDRESS>
</FILER>

<DOCUMENT>
<TYPE>		DRS
<SEQUENCE>	1
<FILENAME>	filename1.htm
<TEXT>
<HTML>
       Show <HTML>: 22,053 lines (widest: 261 characters) - 2M bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-3
<SEQUENCE>	2
<FILENAME>	filename2.htm
<TEXT>
<HTML>
       Show <HTML>: 425 lines (widest: 249 characters) - 76K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-3
<SEQUENCE>	3
<FILENAME>	filename3.htm
<TEXT>
<HTML>
       Show <HTML>: 448 lines (widest: 249 characters) - 79K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4
<SEQUENCE>	4
<FILENAME>	filename4.htm
<TEXT>
<HTML>
       Show <HTML>: 1,548 lines (widest: 254 characters) - 158K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	5
<FILENAME>	filename5.htm
<TEXT>
<HTML>
       Show <HTML>: 407 lines (widest: 249 characters) - 74K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	6
<FILENAME>	filename6.htm
<TEXT>
<HTML>
       Show <HTML>: 477 lines (widest: 249 characters) - 60K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	7
<FILENAME>	filename7.htm
<TEXT>
<HTML>
       Show <HTML>: 283 lines (widest: 249 characters) - 50K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	8
<FILENAME>	filename8.htm
<TEXT>
<HTML>
       Show <HTML>: 2,624 lines (widest: 249 characters) - 265K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	9
<FILENAME>	filename9.htm
<TEXT>
<HTML>
       Show <HTML>: 542 lines (widest: 249 characters) - 43K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	10
<FILENAME>	filename10.htm
<TEXT>
<HTML>
       Show <HTML>: 785 lines (widest: 249 characters) - 72K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	11
<FILENAME>	filename11.htm
<TEXT>
<HTML>
       Show <HTML>: 751 lines (widest: 249 characters) - 89K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	12
<FILENAME>	filename12.htm
<TEXT>
<HTML>
       Show <HTML>: 121 lines (widest: 249 characters) - 17K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	13
<FILENAME>	filename13.htm
<TEXT>
<HTML>
       Show <HTML>: 88 lines (widest: 249 characters) - 10K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	14
<FILENAME>	filename14.htm
<TEXT>
<HTML>
       Show <HTML>: 119 lines (widest: 249 characters) - 17K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	15
<FILENAME>	filename15.htm
<TEXT>
<HTML>
       Show <HTML>: 86 lines (widest: 249 characters) - 10K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	16
<FILENAME>	filename16.htm
<TEXT>
<HTML>
       Show <HTML>: 118 lines (widest: 249 characters) - 17K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	17
<FILENAME>	filename17.htm
<TEXT>
<HTML>
       Show <HTML>: 86 lines (widest: 249 characters) - 10K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	18
<FILENAME>	filename18.htm
<TEXT>
<HTML>
       Show <HTML>: 119 lines (widest: 249 characters) - 17K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-10
<SEQUENCE>	19
<FILENAME>	filename19.htm
<TEXT>
<HTML>
       Show <HTML>: 93 lines (widest: 249 characters) - 10K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-21
<SEQUENCE>	20
<FILENAME>	filename20.htm
<TEXT>
<HTML>
       Show <HTML>: 28 lines (widest: 242 characters) - 2K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	21  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exr_pg19.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 2,507 lines (Unix-to-Unix encoding) - 152K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	22  ⇐ Not a Document/Exhibit
<FILENAME>	g657876g18j62.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 790 lines (Unix-to-Unix encoding) - 48K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	23  ⇐ Not a Document/Exhibit
<FILENAME>	g657876g31d69.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 1,357 lines (Unix-to-Unix encoding) - 82K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	24  ⇐ Not a Document/Exhibit
<FILENAME>	g657876g32k28.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 719 lines (Unix-to-Unix encoding) - 44K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	25  ⇐ Not a Document/Exhibit
<FILENAME>	g657876g39f57.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 477 lines (Unix-to-Unix encoding) - 29K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	26  ⇐ Not a Document/Exhibit
<FILENAME>	g657876g42y11.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 929 lines (Unix-to-Unix encoding) - 57K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	27  ⇐ Not a Document/Exhibit
<FILENAME>	g657876g51n96.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 1,275 lines (Unix-to-Unix encoding) - 78K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	28  ⇐ Not a Document/Exhibit
<FILENAME>	g657876g68h64.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 341 lines (Unix-to-Unix encoding) - 21K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	29  ⇐ Not a Document/Exhibit
<FILENAME>	g657876g84d45.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 706 lines (Unix-to-Unix encoding) - 43K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	30  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exo_pg33.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 2,261 lines (Unix-to-Unix encoding) - 137K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	31  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exo_pg34.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 2,830 lines (Unix-to-Unix encoding) - 172K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	32  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exp_pg07.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 4,185 lines (Unix-to-Unix encoding) - 254K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	33  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exp_pg08.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 2,749 lines (Unix-to-Unix encoding) - 167K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	34  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exp_pg09.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 3,031 lines (Unix-to-Unix encoding) - 184K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	35  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exp_pg10.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 2,939 lines (Unix-to-Unix encoding) - 178K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	36  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exq_pg06.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 2,903 lines (Unix-to-Unix encoding) - 176K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	37  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exq_pg07.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 3,234 lines (Unix-to-Unix encoding) - 196K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	38  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exq_pg08.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 4,080 lines (Unix-to-Unix encoding) - 247K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	39  ⇐ Not a Document/Exhibit
<FILENAME>	g664176exq_pg17.jpg
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 3,872 lines (Unix-to-Unix encoding) - 235K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0000950123-14-001346 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Alder Biopharmaceuticals Inc – ‘DRS’ from 2/7/14

On: Friday, 2/7/14, at 8:56pm ET · As of: 2/10/14 · Private-to-Public: Filing ¶ – Release Delayed to: 3/19/14 · Accession #: 950123-14-1346 · File #: 377-00475

1 Reference: By: SEC – ‘UPLOAD’ on 3/10/14

Delayed-Release Draft Registration Statement by an Emerging Growth Company or a Foreign Private Issuer — Form DRSFiling Table of Contents

On: Friday, 2/7/14, at 8:56pm ET · As of: 2/10/14 · Private-to-Public: Filing `¶` – Release Delayed to: 3/19/14 · Accession #: 950123-14-1346 · File #: 377-00475

Delayed-Release Draft Registration Statement by an Emerging Growth Company or a Foreign Private Issuer — Form DRS
Filing Table of Contents